Viewing Study NCT07492004


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 12:27 AM
Study NCT ID: NCT07492004
Status: RECRUITING
Last Update Posted: 2026-03-25
First Post: 2026-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: China Monogenic Diabetes Registry
Sponsor: Tianjin Medical University General Hospital
Organization:

Study Overview

Official Title: China Monogenic Diabetes Registry
Status: RECRUITING
Status Verified Date: 2026-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CMDR
Brief Summary: This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to:

Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution

Participants will:

* Enroll in the monogenic diabetes registry via mobile application or web-based platform
* Undergo molecular genetic testing to establish a definitive diagnosis
Detailed Description: This study will include the subjects of a series of studies on monogenic diabetes conducted by our team, including neonatal diabetes, maturity-onset diabetes of the young, maternally inherited diabetes and deafness, and other monogenic diabetes caused by different causative genes, and establish a large sample database and specimen bank through follow-up and omics analysis.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: